CESSATECH A/S DK -20

Research CESSATECH A/S DK -20 (8GN) on Bullrun: market cap EUR 22.20M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker8GN
ExchangeF
CountryDenmark
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 22.20M
Financial periodQ1 2026
RevenueDKK 0
Net income-DKK 3.23M
Free cash flow-DKK 3.28M

Valuation Snapshot

latest market cap is EUR 22.20M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	DKK 5.72M	-DKK 10.90M	-DKK 17.58M	n/a	n/a	DKK 8.59M	n/a	DKK 12.16M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	EUR 22.20M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About CESSATECH A/S DK -20

Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development.

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

Strategic Partners A/S (1TB0) 2cureX AB (2CUREX) FLUOGUIDE A/S DK -1 (96X) ALK-Abelló A/S (ALK-B) Ascendis Pharma A/S (ASND) Bavarian Nordic A/S (BV3A) Evaxion Biotech A/S (EVAX) GENMAB (GE9) Genmab (GMAB) Gubra A/S (GUBRA) Initiator Pharma A/S (INIT) Pharma Equity Group (PEG.CO)

Frequently asked questions

What is CESSATECH A/S DK -20's market cap?

CESSATECH A/S DK -20's market capitalization is EUR 22.20M.